<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38371381</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-3546</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Brain, behavior, &amp; immunity - health</Title><ISOAbbreviation>Brain Behav Immun Health</ISOAbbreviation></Journal><ArticleTitle>rTMS for post-covid-19 condition: A sham-controlled case series involving iTBS-300 and iTBS-600.</ArticleTitle><Pagination><StartPage>100736</StartPage><MedlinePgn>100736</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100736</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbih.2024.100736</ELocationID><Abstract><AbstractText>Post-Covid-19 Condition (PCC) is a syndrome comprised of symptoms persisting 3 months or more beyond SARS-CoV-2 primary infection. It is typically characterized by fatigue, cognitive problems and psychiatric symptoms, as well as cardiac symptoms that contribute to exercise intolerance in many. Despite the high prevalence of PCC among those with a prior SARS-CoV-2 infection, there is currently no widely accepted rehabilitation strategy, and many conventional modalities are movement-based. Non-invasive brain stimulation methods such as repetitive transcranial magnetic stimulation (rTMS) may have some potential to alleviate the cognitive and affective symptoms of PCC without reliance on exercise. The purpose of the present study was to explore the feasibility and tolerability of using rTMS to treat symptoms of "brain fog" and affective disturbance among those living with PCC, using a case series design. We enrolled four individuals with PCC following a confirmed SARS-CoV-2 infection, at least 3 months after the resolution of the primary infection. Participants were randomized to 4 sessions of active and 2 sessions of sham intermittent theta-burst stimulation (iTBS); two intensities of iTBS were evaluated: iTBS-300 and iTBS-600. No adverse events occurred in active or sham stimulation; 2 participants reported tingling sensation on the scalp but no other tolerability issues. Trends in symptoms suggested improvements in cognitive interference, quality of life, and anxiety in the majority of participants. In summary, in this case series iTBS was well tolerated among 4 individuals with PCC; active stimulation was associated with positive trends in some primary symptom clusters as compared with sham stimulation. Future studies should examine the effects of iTBS on PCC symptoms in the context of experimental studies and randomized controlled trials.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sakib</LastName><ForeName>Mohammad Nazmus</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saragadam</LastName><ForeName>Ashish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santagata</LastName><ForeName>Mariella C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jolicoeur-Becotte</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozyr</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burhan</LastName><ForeName>Amer M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Ontario Shores Centre for Mental Health Sciences, Whitby, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Bioengineering and Biotechnology, University of Waterloo, Waterloo, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav Immun Health</MedlineTA><NlmUniqueID>101759062</NlmUniqueID><ISSNLinking>2666-3546</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain stimulation</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Case series</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">PCC</Keyword><Keyword MajorTopicYN="N">rTMS</Keyword></KeywordList><CoiStatement>Authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>4</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38371381</ArticleId><ArticleId IdType="pmc">PMC10869745</ArticleId><ArticleId IdType="doi">10.1016/j.bbih.2024.100736</ArticleId><ArticleId IdType="pii">S2666-3546(24)00014-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H.&#x2026;Shahisavandi M. Long COVID syndrome-associated brain fog. J. Med. Virol. 2022;94(3):979&#x2013;984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkley R. Guilford Press; New York: 2011. Barkley Deficits in Executive Functioning Scale (BDEFS) [Google Scholar]</Citation></Reference><Reference><Citation>Begemann M.J., Brand B.A., &#x106;ur&#x10d;i&#x107;-Blake B., Aleman A., Sommer I.E. Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis. Psychol. Med. 2020;50(15):2465&#x2013;2486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737055</ArticleId><ArticleId IdType="pubmed">33070785</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke M.J., Romanella S.M., Mencarelli L., Greben R., Fox M.D., Kaptchuk T.J., et al. Placebo effects and neuromodulation for depression: a meta-analysis and evaluation of shared mechanisms. Mol. Psychiatr. 2022;27(3):1658&#x2013;1666.</Citation><ArticleIdList><ArticleId IdType="pubmed">34903861</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksen B.A., Eriksen C.W. Effects of noise letters upon the identification of a target letter in a nonsearch task. Percept. Psychophys. 1974;16(1):143&#x2013;149. doi: 10.3758/BF03203267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/BF03203267</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald P.B., Hoy K., McQueen S., Maller J.J., Herring S., Segrave R.&#x2026;Daskalakis Z.J. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology. 2009;34(5):1255&#x2013;1262. doi: 10.1038/npp.2008.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2008.233</ArticleId><ArticleId IdType="pubmed">19145228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall P.A., Ayaz H., Meng G., Hudson A., Sakib M.N., Quah A.C.K.&#x2026;Fong G.T. Neurocognitive and psychiatric symptoms following infection with COVID-19: evidence from laboratory and population studies. Brain Behav Immun Health. 2023;28 doi: 10.1016/j.bbih.2023.100595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100595</ArticleId><ArticleId IdType="pmc">PMC9870612</ArticleId><ArticleId IdType="pubmed">36713476</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.-Z., Edwards M.J., Rounis E., Bhatia K.P., Rothwell J.C. Theta burst stimulation of the human motor cortex. Neuron. 2005;45(2):201&#x2013;206. doi: 10.1016/j.neuron.2004.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.12.033</ArticleId><ArticleId IdType="pubmed">15664172</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J. Am. Geriatr. Soc. 1983;31(12):721&#x2013;727. doi: 10.1111/j.1532-5415.1983.tb03391.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.1983.tb03391.x</ArticleId><ArticleId IdType="pubmed">6418786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawabata Y., Imazu S.I., Matsumoto K., Toyoda K., Kawano M., Kubo Y.&#x2026;Kanazawa T. rTMS therapy reduces hypofrontality in patients with depression as measured by fNIRS. Front. Psychiatr. 2022;13 doi: 10.3389/fpsyt.2022.814611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.814611</ArticleId><ArticleId IdType="pmc">PMC9257165</ArticleId><ArticleId IdType="pubmed">35815029</ArticleId></ArticleIdList></Reference><Reference><Citation>Koffarnus M.N., Bickel W.K. A 5-trial adjusting delay discounting task: accurate discount rates in less than one minute. Exp. Clin. Psychopharmacol. 2014;22(3):222&#x2013;228. doi: 10.1037/a0035973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0035973</ArticleId><ArticleId IdType="pmc">PMC4461028</ArticleId><ArticleId IdType="pubmed">24708144</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam G.Y., Damant R.W., Ferrara G., Lim R.K., Stickland M.K., Ogando N.S.&#x2026;Smith M.P. Characterizing long-COVID brain fog: a retrospective cohort study. J. Neurol. 2023;270(10):4640&#x2013;4646. doi: 10.1007/s00415-023-11913-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-11913-w</ArticleId><ArticleId IdType="pubmed">37555926</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontol. 1969;9(3):179&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">5349366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe C.J., Manocchio F., Safati A.B., Hall P.A. The effects of theta burst stimulation (TBS) targeting the prefrontal cortex on executive functioning: a systematic review and meta-analysis. Neuropsychologia. 2018;111:344&#x2013;359. doi: 10.1016/j.neuropsychologia.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropsychologia.2018.02.004</ArticleId><ArticleId IdType="pubmed">29438672</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J., Robineau O., Wiernik E., Carrat F., Severi G., Touvier M., et al. Depression and anxiety before and at the beginning of the COVID-19 pandemic and incident persistent symptoms: a prospective population-based cohort study. Mol. Psychiatr. 2023:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">37464077</ArticleId></ArticleIdList></Reference><Reference><Citation>McClintock S.M., Reti I.M., Carpenter L.L., McDonald W.M., Dubin M., Taylor S.F.&#x2026;Treatments Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J. Clin. Psychiatr. 2018;79(1) doi: 10.4088/JCP.16cs10905. 16cs10905.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.16cs10905</ArticleId><ArticleId IdType="pmc">PMC5846193</ArticleId><ArticleId IdType="pubmed">28541649</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollica A., Safavifar F., Fralick M., Giacobbe P., Lipsman N., Burke M.J. Transcranial magnetic stimulation for the treatment of concussion: a systematic review. Neuromodulation. 2021;24(5):803&#x2013;812. doi: 10.1111/ner.13319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ner.13319</ArticleId><ArticleId IdType="pubmed">33184973</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray M.M., Foxe J.J., Higgins B.A., Javitt D.C., Schroeder C.E. Visuo-spatial neural response interactions in early cortical processing during a simple reaction time task: a high-density electrical mapping study. Neuropsychologia. 2001;39(8):828&#x2013;844. doi: 10.1016/s0028-3932(01)00004-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0028-3932(01)00004-5</ArticleId><ArticleId IdType="pubmed">11369406</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Desai A.D., Wan E.Y. Post-COVID-19 condition. Annu. Rev. Med. 2022 doi: 10.1146/annurev-med-043021-030635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-030635</ArticleId><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda Y., Sato A., Shichi M., Sato A., Fujii K., Iwasa M.&#x2026;Osawa R. Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan. Asian Journal of Psychiatry. 2023;81 doi: 10.1016/j.ajp.2022.103438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2022.103438</ArticleId><ArticleId IdType="pmc">PMC9795803</ArticleId><ArticleId IdType="pubmed">36610206</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh T.K., Strawn J.R., Walkup J.T., Croarkin P.E. Repetitive transcranial magnetic stimulation for generalized anxiety disorder: a systematic literature review and meta-analysis. Int. J. Neuropsychopharmacol. 2022;25(2):144&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8832221</ArticleId><ArticleId IdType="pubmed">34791241</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. Screening questionnaire before TMS: an update. Clin. Neurophysiol. 2011;122(8):1686. doi: 10.1016/j.clinph.2010.12.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2010.12.037</ArticleId><ArticleId IdType="pubmed">21227747</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki N., Yamatoku M., Tsuchida T., Sato H., Yamaguchi K. Effect of repetitive transcranial magnetic stimulation on long coronavirus disease 2019 with fatigue and cognitive dysfunction. Prog Rehabil Med. 2023;8 doi: 10.2490/prm.20230004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2490/prm.20230004</ArticleId><ArticleId IdType="pmc">PMC9968785</ArticleId><ArticleId IdType="pubmed">36861061</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan K.H., Sheehan D.V. Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int. Clin. Psychopharmacol. 2008;23(2):70&#x2013;83. doi: 10.1097/YIC.0b013e3282f2b4d6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YIC.0b013e3282f2b4d6</ArticleId><ArticleId IdType="pubmed">18301121</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinjo S.K., Brunoni A.R., Okano A.H., Tanaka C., Baptista A.F. Transcranial direct current stimulation relieves the severe anxiety of a patient with COVID-19. Brain Stimul. 2020;13(5):1352&#x2013;1353. doi: 10.1016/j.brs.2020.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2020.07.004</ArticleId><ArticleId IdType="pmc">PMC7366123</ArticleId><ArticleId IdType="pubmed">32682750</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer R.L., Kroenke K., Williams J.B., L&#xf6;we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 2006;166(10):1092&#x2013;1097. doi: 10.1001/archinte.166.10.1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files D.C., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. Morb. Mortal. Wkly. Rep. 2020;69(30):993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A.&#x2026;Zisis S. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023 doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>The Whoqol Group The world health organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc. Sci. Med. 1998;46(12):1569&#x2013;1585. doi: 10.1016/s0277-9536(98)00009-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0277-9536(98)00009-4</ArticleId><ArticleId IdType="pubmed">9672396</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys. Ther. 2022;102(4) doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Valiengo L., Maia A., Cotovio G., Gordon P.C., Brunoni A.R., Forlenza O.V., Oliveira-Maia A.J. Repetitive transcranial magnetic stimulation for major depressive disorder in older adults: systematic review and meta-analysis. J. Gerontol.: Series A. 2022;77(4):851&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pubmed">34432865</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>